Publications by authors named "Nancy Claude"

Claim this Profile
N
New limits proposed for the management of non-mutagenic impurities.
Anja Slikkerveer, Olaf Doehr, Nancy Claude, Richard Hutchinson, James Harvey

Regul Toxicol Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs).
Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, Priyanka Sura, Robert Jolly, Nancy Claude

Regul Toxicol Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Registered Toxicologist (ERT): Current status and prospects for advancement.
Martin F Wilks, Bas J Blaauboer, Rolf Schulte-Hermann, Heather M Wallace, Corrado L Galli, Nancy Claude

Toxicol Lett· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotoxicity of tungsten carbide-cobalt (WC-Co) nanoparticles in vitro: mechanisms-of-action studies.
Hélène Moche, Dany Chevalier, Hervé Vezin, Nancy Claude, Elisabeth Lorge

Mutat Res Genet Toxicol Environ Mutagen· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Alexandra Rogue, Sébastien Anthérieu, Aurore Vluggens, Thierry Umbdenstock, Nancy Claude

Toxicol Appl Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tungsten carbide-cobalt as a nanoparticulate reference positive control in in vitro genotoxicity assays.
Hélène Moche, Dany Chevalier, Nicolas Barois, Elisabeth Lorge, Nancy Claude

Toxicol Sci· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells.
Alexandra Rogue, Carine Lambert, Catherine Spire, Nancy Claude, André Guillouzo

Drug Metab Dispos· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the in vitro modified comet assay: determination of No-Observed-Genotoxic-Effect-Levels.
Anne Platel, Fabrice Nesslany, Véronique Gervais, Nancy Claude, Daniel Marzin

Mutat Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.
Alexandra Rogue, Catherine Spire, Manuel Brun, Nancy Claude, André Guillouzo

PPAR Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.
Alexandra Rogue, Marie Pierre Renaud, Nancy Claude, André Guillouzo, Catherine Spire

Toxicol Appl Pharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes.
Alexandra Rogue, Carine Lambert, Rozenn Jossé, Sebastien Antherieu, Catherine Spire, Nancy Claude

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of gene expression profiles in TK6 human cells exposed to DNA-oxidizing agents.
Anne Platel, Véronique Gervais, Nicolas Sajot, Fabrice Nesslany, Daniel Marzin, Nancy Claude

Mutat Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cells technologies in toxicology assessments.
Nancy Claude, Maria Christakis, Aristidis M Tsatsakis

Toxicology· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reducing the use of laboratory animals].
Nancy Claude

Bull Acad Natl Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions.
Carine B Lambert, Catherine Spire, Marie-Pierre Renaud, Nancy Claude, Andre Guillouzo

Toxicol In Vitro· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.
Carine B Lambert, Catherine Spire, Nancy Claude, Andre Guillouzo

Toxicol Appl Pharmacol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[In silico, in vitro, in omic experimental models and drug safety evaluation].
Nancy Claude, Françoise Goldfain-Blanc, André Guillouzo

Med Sci (Paris)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic toxicity assessment: employing the best science for human safety evaluation part IV: a strategy in genotoxicity testing in drug development: some examples.
Elisabeth Lorge, Véronique Gervais, Nathalie Becourt-Lhote, Catherine Maisonneuve, Jean-Luc Delongeas, Nancy Claude

Toxicol Sci· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic toxicity assessment: employing the best science for human safety evaluation. Part II: Performances of the in vitro micronucleus test compared to the mouse lymphoma assay and the in vitro chromosome aberration assay.
Elisabeth Lorge, Carine Lambert, Véronique Gervais, Nathalie Becourt-Lhote, Jean-Luc Delongeas, Nancy Claude

Toxicol Sci· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of in vitro models for the assessment of drug-induced haematotoxicity.
Françoise Goldfain-Blanc, Olivier Wattrelos, Nicole Casadevall, Anne Beamonte, Jean-Luc Delongeas, Nancy Claude

Therapie· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
Jean-Roger Claude, Nancy Claude

Toxicol Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis